VISCARDIA

Two thirds of patients for whom drugs are inadequate only have complicated surgical procedures to endure for a hope of feeling better. VisCardia has developed a minimally-invasive alternative... VisCardia aims to change today's heart failure treatment paradigm with its novel therapy for patients with reduced ejection fraction and preserved ventricular synchrony... VisCardia Inc., a privately held medical device developer in Portland Oregon, is developing a new implantable device therapy for heart failure.

Also known as: VisCardia, Inc.

Primary location: Beaverton United States